Back
Cartesian Therapeutics, Inc. Stock Price Chart
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$6.90
Seasonality Move:
7.79%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cartesian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.18 | Sell |
| 20-day SMA: | 7.31 | Sell |
| 50-day SMA: | 8.47 | Sell |
| 200-day SMA: | 11.18 | Sell |
| 8-day EMA: | 7.07 | Sell |
| 20-day EMA: | 7.41 | Sell |
| 50-day EMA: | 8.27 | Sell |
| 200-day EMA: | 11.3 | Sell |
Cartesian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 38.12 | Sell |
| Chaikin Money Flow: | 209549 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.06 - 7.82) | Sell |
| Bollinger Bands (100): | (8.02 - 11.6) | Sell |
Cartesian Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics, Inc. Stock
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 6.90 while RNAC 8-day simple moving average is 7.18, which is a Sell signal.
-
The stock price of RNAC is 6.90 while Cartesian Therapeutics, Inc. 20-day SMA is 7.31, which makes it a Sell.
-
Cartesian Therapeutics, Inc. 50-day simple moving average is 8.47 while RNAC share price is 6.90, making it a Sell technically.
-
RNAC stock price is 6.90 and Cartesian Therapeutics, Inc. 200-day simple moving average is 11.18, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
37
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. a Buy or a Sell?
-
Cartesian Therapeutics, Inc. stock is rated a SellThe current Cartesian Therapeutics, Inc. [RNAC] share price is $6.90. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics, Inc. Stock Info
Market Cap:
179.4M
Price in USD:
6.90
Share Volume:
364.8K
Cartesian Therapeutics, Inc. 52-Week Range
52-Week High:
26.50
52-Week Low:
5.98
Sell
37
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Cartesian Therapeutics, Inc. Share Price Forecast
-
What is the Cartesian Therapeutics, Inc. stock price today?The Cartesian Therapeutics, Inc. stock price is 6.90 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics, Inc. is overvalued.
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 6.90 while RNAC 8-day exponential moving average is 7.07, which is a Sell signal.
-
The stock price of RNAC is 6.90 while Cartesian Therapeutics, Inc. 20-day EMA is 7.41, which makes it a Sell.
-
Cartesian Therapeutics, Inc. 50-day exponential moving average is 8.27 while RNAC share price is 6.90, making it a Sell technically.
-
RNAC stock price is 6.90 and Cartesian Therapeutics, Inc. 200-day simple moving average is 11.30, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics, Inc.
Is Cartesian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.19 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Cartesian Therapeutics, Inc.
Should I short Cartesian Therapeutics, Inc. stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is -0.41, suggesting Cartesian Therapeutics, Inc. is a Sell
-
Cartesian Therapeutics, Inc. Relative Strength Index (RSI) is 38.12, which suggest Cartesian Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Cartesian Therapeutics, Inc. is (7.06 - 7.82), which suggest Cartesian Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Cartesian Therapeutics, Inc. is (8.02 - 11.6), which suggest Cartesian Therapeutics, Inc. is a Sell
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.